EP2392576
ICOTINIB HYDROCHLORIDE, SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.7.2009EP published:
17.2.2016EP application number:
09793788.2
EPO information:
European Patent Register
Max expiry date:
6.7.2029
Title:
ICOTINIB HYDROCHLORIDE, SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF
Timeline
Today
7.7.2009EP application
17.2.2016EP Publication
Owner
Name:
Beta Pharma, Inc.Address:
5 Vaughn Drive, Suite 106, 08540, Princeton, NJ, US
Inventor
Name:
WANG, YinxiangAddress:
Beijing, CN
Name:
DING, LiemingAddress:
HangzhouZhejiang, CN
Name:
TAN, FenlaiAddress:
Beijing, CN
Name:
HU, YunyanAddress:
Beijing, CN
Name:
HE, WeiAddress:
Beijing, CN
Name:
HAN, BinAddress:
Beijing, CN
Name:
LONG, WeiAddress:
Beijing, CN
Name:
LIU, YongAddress:
Beijing, CN
Name:
AL, HaimaAddress:
Beijing, CN
Name:
ZHANG, DonAddress:
Branford, Connecticut, US
Name:
DAVIS, CharlesAddress:
Branford, Connecticut, US
Name:
XIE, GuojianAddress:
Branford, Connecticut, US
Priority
Number:
200810132631Date:
8.7.2008Country:
CN
Number:
200810132458Date:
17.7.2008Country:
CN
Number:
200810188272Date:
23.12.2008Country:
CN
Classification
Categories:
C07D 491/056, A61K 31/519, A61P 35/00